FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091988081> ?p ?o ?g. }

• W3091988081 endingPage "104987" @default.
• W3091988081 startingPage "104987" @default.
• W3091988081 abstract "Candida infections represent a threat to human health. Candida albicans is the main causative agent of invasive candidiasis, especially in immunosuppressed patients. The emergence of resistant strains has required the development of new therapeutic strategies. In this context, the use of liposomes as drug carrier systems is a promising alternative in drug development. Thus, considering the evidence demonstrating that sesquiterpene farnesol is a bioactive compound with antifungal properties, this study evaluated the activity farnesol-containing liposomes against different Candida strains. The IC50 of farnesol and its liposomal formulation was assessed in vitro using cultures of Candida albicans, Candida tropicalis, and Candida krusei. The Minimum Fungicidal Concentration (MFC) was established by subculture in solid medium. The occurrence of fungal dimorphism was analyzed using optical microscopy. The effects on antifungal resistance to fluconazole were assessed by evaluating the impact of combined therapy on the growth of Candida strains. The characterization of liposomes was carried out considering their vesicular size, polydispersion index, and zeta medium potential, in addition to electron microscopy analysis. Farnesol exerted an antifungal activity that might be associated with the inhibition of fungal dimorphism, especially in Candida albicans. The incorporation of farnesol into liposomes significantly increased its antifungal activity against C. albicans, C. tropicalis, and C. krusei. In addition, liposomal farnesol potentiated the action of fluconazole against C. albicans and C. tropicalis. On the other hand, the association of unconjugated farnesol with fluconazole resulted in antagonistic effects. In conclusion, farnesol-containing liposomes have the potential to be used in antifungal drug development. However, further research is required to investigate how the antifungal properties of farnesol are affected by the interaction with liposomes, contributing to the modulation of antifungal resistance to conventional drugs." @default.
• W3091988081 created "2020-10-15" @default.
• W3091988081 creator A5002085077 @default.
• W3091988081 creator A5002999558 @default.
• W3091988081 creator A5004570226 @default.
• W3091988081 creator A5007985332 @default.
• W3091988081 creator A5014958672 @default.
• W3091988081 creator A5020419267 @default.
• W3091988081 creator A5021850194 @default.
• W3091988081 creator A5025128327 @default.
• W3091988081 creator A5028791718 @default.
• W3091988081 creator A5031753550 @default.
• W3091988081 creator A5032285188 @default.
• W3091988081 creator A5048275802 @default.
• W3091988081 creator A5052291203 @default.
• W3091988081 creator A5057947821 @default.
• W3091988081 creator A5058715641 @default.
• W3091988081 creator A5060442760 @default.
• W3091988081 creator A5071256690 @default.
• W3091988081 creator A5071703141 @default.
• W3091988081 creator A5072843751 @default.
• W3091988081 creator A5073740097 @default.
• W3091988081 creator A5077960361 @default.
• W3091988081 date "2020-11-01" @default.
• W3091988081 modified "2023-10-14" @default.
• W3091988081 title "Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole" @default.
• W3091988081 cites W1564553363 @default.
• W3091988081 cites W1598760153 @default.
• W3091988081 cites W1907600699 @default.
• W3091988081 cites W1982607491 @default.
• W3091988081 cites W1990927815 @default.
• W3091988081 cites W1997330469 @default.
• W3091988081 cites W1997594388 @default.
• W3091988081 cites W2006478107 @default.
• W3091988081 cites W2009134735 @default.
• W3091988081 cites W2010886618 @default.
• W3091988081 cites W2022100000 @default.
• W3091988081 cites W2031213053 @default.
• W3091988081 cites W2045393193 @default.
• W3091988081 cites W2062667259 @default.
• W3091988081 cites W2076226743 @default.
• W3091988081 cites W2090296204 @default.
• W3091988081 cites W2100475145 @default.
• W3091988081 cites W2104825748 @default.
• W3091988081 cites W2110843437 @default.
• W3091988081 cites W2114925097 @default.
• W3091988081 cites W2120398300 @default.
• W3091988081 cites W2125735344 @default.
• W3091988081 cites W2129637849 @default.
• W3091988081 cites W2131805915 @default.
• W3091988081 cites W2134643642 @default.
• W3091988081 cites W2135851681 @default.
• W3091988081 cites W2144035662 @default.
• W3091988081 cites W2144677145 @default.
• W3091988081 cites W2149987266 @default.
• W3091988081 cites W2151238839 @default.
• W3091988081 cites W2153687682 @default.
• W3091988081 cites W2156385589 @default.
• W3091988081 cites W2158528341 @default.
• W3091988081 cites W2165781451 @default.
• W3091988081 cites W2193631490 @default.
• W3091988081 cites W2225712184 @default.
• W3091988081 cites W2295676242 @default.
• W3091988081 cites W2470097662 @default.
• W3091988081 cites W2540081690 @default.
• W3091988081 cites W2549262105 @default.
• W3091988081 cites W2549380283 @default.
• W3091988081 cites W2593467830 @default.
• W3091988081 cites W2599358047 @default.
• W3091988081 cites W2625766277 @default.
• W3091988081 cites W2626726666 @default.
• W3091988081 cites W2782394839 @default.
• W3091988081 cites W2793822567 @default.
• W3091988081 cites W2908752561 @default.
• W3091988081 cites W2921160365 @default.
• W3091988081 cites W2922388167 @default.
• W3091988081 cites W2984181782 @default.
• W3091988081 cites W3000652845 @default.
• W3091988081 cites W3012817514 @default.
• W3091988081 cites W4211042503 @default.
• W3091988081 cites W4213016631 @default.
• W3091988081 doi "https://doi.org/10.1016/j.chemphyslip.2020.104987" @default.
• W3091988081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33058818" @default.
• W3091988081 hasPublicationYear "2020" @default.
• W3091988081 type Work @default.
• W3091988081 sameAs 3091988081 @default.
• W3091988081 citedByCount "16" @default.
• W3091988081 countsByYear W30919880812021 @default.
• W3091988081 countsByYear W30919880812022 @default.
• W3091988081 countsByYear W30919880812023 @default.
• W3091988081 crossrefType "journal-article" @default.
• W3091988081 hasAuthorship W3091988081A5002085077 @default.
• W3091988081 hasAuthorship W3091988081A5002999558 @default.
• W3091988081 hasAuthorship W3091988081A5004570226 @default.
• W3091988081 hasAuthorship W3091988081A5007985332 @default.
• W3091988081 hasAuthorship W3091988081A5014958672 @default.
• W3091988081 hasAuthorship W3091988081A5020419267 @default.
• W3091988081 hasAuthorship W3091988081A5021850194 @default.

• next